CVE:KLH Stellar Biotechnologies (KLH) Stock Price, News & Analysis → The Gold Grab of the Century (From Colonial Metals) (Ad) Free KLH Stock Alerts Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume5,576 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Stellar Biotechnologies alerts: Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About Stellar Biotechnologies Stock (CVE:KLH)Stellar Biotechnologies, Inc. is a biotechnology company. The Company is engaged in the aquaculture, research and development, manufacture and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-targeting agent to create immunotherapies for the treatment of a range of diseases. The Company's core business is developing and commercializing Keyhole Limpet Hemocyanin for use in immunotherapy and immunodiagnostic applications. The Company's Stellar KLH product offerings include Stellar KLH protein for conjugation and as carrier molecule in immunotherapy development; Stellar KLH protein and enzyme-linked immunosorbent assay (ELISA) test kits for immune function testing, and Custom KLH formulations, adjuvants, conjugations and fill finishes for preclinical research and drug development applications.Read More Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. KLH Stock News HeadlinesSeptember 22, 2023 | nypost.comYankees can’t complete sweep of Pirates despite stellar Carlos Rodon startMay 30, 2023 | forbes.comConvert Stellar To BitcoinApril 26, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.May 16, 2023 | marketwatch.comKeyhole Limpet Hemocyanin (KLH) Market Research and Size Analysis 2023-2030May 11, 2023 | marketwatch.comKeyhole Limpet Hemocyanin Market Top Competitors and Prediction Till 2030May 5, 2023 | marketwatch.comNewest Analysis On "Keyhole Limpet Hemocyanin (KLH) Market" Research & Forecast | With 87 PagesMay 5, 2023 | marketwatch.comKeyhole Limpet Hemocyanin (KLH) Market 2023-2030: Future Hypothesize and ascending UpdatesApril 10, 2023 | marketwatch.com2023-2030 Keyhole Limpet Hemocyanin (KLH) Market: HighlightsApril 26, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.February 22, 2023 | chicago.suntimes.comWorking in an onstage dirt patch, ‘Fen’ cast faces hardships and horrors in stellar productionFebruary 14, 2023 | marketwatch.comKeyhole Limpet Hemocyanin (KLH) Market Size, Outlook, Share, Prominent Players, Growth, and Forecast 2028February 7, 2023 | marketwatch.comKeyhole Limpet Hemocyanin Market 2023: Latest Opportunities plus Growing Demand, Company Profile and Growth Rate By 2028January 20, 2023 | marketwatch.comKeyhole Limpet Hemocyanin (KLH) Market Size and Regional Analysis 2023 by Segment, Trends, Revenue Estimates and Forecast to 2027September 6, 2022 | marketwatch.comKeyhole Limpet Hemocyanin (Klh) Market 2022 Drivers Challenges and Their Impact on Growth and Demand Forecast In 2030June 21, 2022 | marketwatch.comGlobal Keyhole Limpet Hemocyanin (KLH) Market 2022: Advance Technology and Highlighted Key Development by 2028See More Headlines Receive KLH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stellar Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolCVE:KLH CUSIPN/A CIKN/A Webstellarbiotechnologies.com Phone+1-805-4882800FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report KLH Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Stellar Biotechnologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Stellar Biotechnologies investors own include XOMA (XOMA), Alnylam Pharmaceuticals (ALNY), Ascent Solar Technologies (ASTI), Aquinox Pharmaceuticals (AQXP), OPKO Health (OPK), (SCMP) (SCMP), Foundation Medicine (FMI), Laredo Petroleum (LPI), (OAKS) (OAKS) and Stellar Biotechnologies (SBOT). How do I buy shares of Stellar Biotechnologies? Shares of KLH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:KLH) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stellar Biotechnologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
